ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 704640 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 704640; 2) Community: the network communities that were significantly associated with the response to NSC 704640; 3) Molecule: the relationships between components within communities and NSC 704640; 4) MDR: the compounds that were significantly associated with the NSC 704640.

NSC Compound Enrichment Correlation
NSC 704280 Null 0.00824865245912294 0.27098837
NSC 708423 Null 0.00824865245912294 0.22618812
NSC 720297 Methyl-7.alpha.,12.alpha.-diacetoxy-5.beta.-cholan-24-oate~ -3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spiro-1"-(4"-t-butyl)cyclohexane 0.00824865245912294 0.42325494
NSC 720447 Null 0.00824865245912294 0.11892033
NSC 721049 7Z-Plakortide H 0.00824865245912294 0.37226591
NSC 722781 trans-bis(acetato)amminepyridineplatinum(II) 0.00824865245912294 0.11114629
NSC 733503 cis-6-(3-Bromopropyl)-12,13-dihydro-8,9-dimethoxy-3-nitro-5, 11-dioxo-11H-indeno[1,2-c]isoquinoline 0.00824865245912294 0.28301469
NSC 740 Methotrexate 0.00824865245912294 -0.070278924
NSC 763703 (Z)-6-chloro-3-((2-(4-methoxyphenyl)-3H-benzo[d]imidazol-5-yl)methylene)indolin-2-one 0.00824865245912294 0.065948043
NSC 707148 Card-20(22)-enolide, 3-[(6-deoxy-3-O-methyl-.beta.-D-galacto pyranosyl)oxy]-14-hydroxy-, (3.beta.,5.beta)- (9CI) 0.0105244982742819 0.16550302
Total:85  Current:23    [First] [Prev] [Next] [Last]